J9309 Injection, polatuzumab vedotin 1mg
Also known as: polatuzumab vedotin, Polivy
Injection of polatuzumab vedotin, 1 milligram. An antibody-drug conjugate targeting CD79b with a microtubule-disrupting payload.
In Plain Language
lymphoma injection; antibody-drug combination
Clinical Context
Used for relapsed/refractory B-cell non-Hodgkin lymphoma with bendamustine and rituximab. Provides durable response in refractory disease.
RVU Information
CPT J9309 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J9309?
CPT J9309 (Injection, polatuzumab vedotin 1mg) is a J Codes (Drugs) code. Injection of polatuzumab vedotin, 1 milligram. An antibody-drug conjugate targeting CD79b with a microtubule-disrupting payload.
How is J9309 administered?
CPT J9309 is administered by a healthcare provider, typically via injection or infusion. Used for relapsed/refractory B-cell non-Hodgkin lymphoma with bendamustine and rituximab. Provides durable response in refractory disease. It is used by Oncology, Hematology, Immunology.
When is CPT J9309 used?
Used for relapsed/refractory B-cell non-Hodgkin lymphoma with bendamustine and rituximab. Provides durable response in refractory disease.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.